References
- Mukherjee K, Jones K. The treatment of dysfunctional uterine bleeding with the Mirena IUS: a survival analysis. Gynaecol Surg 2:251–254.
- Rauramo I, Elo I, Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstet Gynecol 2004;104:1314–1321.
- Xiao B, Wu SC, Chong J, Zeng T, Han LH, Luukkainen T. Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. Fertil Steril 2003;79:963–969.
- Robinson R, China S, Bunkheila A, Powell M. Mirena intrauterine system in the treatment of menstrual disorders: a survey of UK patients' experience, acceptability and satisfaction. J Obst Gynaecol 2008;28:728–731.
- Kaunitz AM, Meredith S, Inki P, Kubba A, Sanchez-Ramos L. Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis. Obstet Gynecol 2009;113:1104–1116.
- Wildemeersch D, Janssens D, Andrade A. The Femilis LNG-IUS: contraceptive performance – an interim analysis. Eur J Contracept RHC 2009;14:103–110.
- Luukkainen T, Allonen H, Haukkamaa M, et al. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicentre study. Contraception 1987;36:169–179.
- Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56–72.
- Backman T, Huhtala S, Luoto R, Tuominen J, Rauramo I, Koskenvuo M. Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstet Gynaecol 2002;99:608–613.
- Dennerstein L, Fotherby K, Burrows GD, Laby B, Wood C. Plasma levels of ethinyl oestradiol and norgestrel during hormone replacement therapy. Maturitas 1980;2:147–154.
- Nilsson CG, Haukkamaa M, Vierola H, Luukkainen T. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin Endocrinol (Oxf) 1982;17:529–536.
- Ratsula K, Toivonen J, Lahteenmaki P, Luukkainen T. Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device. Contraception 1989;39:195–204.
- Witting K, Santtila P, Jern P, et al. Evaluation of the female sexual function index in a population based sample from Finland. Arch Sex Behav 2008;37:912–924.
- Halmesmäki, et al. A randomized controlled trial of hysterectomy or the levonorgestrel-releasing intrauterine system in the treatment of menorrhagia – effect on FSH levels and menopausal symptoms. Hum Repr 2004;19:378–382.
- Curtis R, Inki P. Response to the Letter to the Editor by Wahab & Al Azzawi. BJOG 2006;113:248–249.
- Daud S, Ewies AA. Levonorgestrel-releasing intrauterine system: why do some women dislike it? Gynecol Endocrinol 2008;24:686–690.
- Weiner E, Victor A, Johansson ED. Plasma levels of D-norgestrel after oral administration. Contraception 1976;14:563–570.
- Suhonen SP, Allonen HO, Lahteenmaki P. Sustained-release estradiol implants and a levonorgestrel-releasing intrauterine device in hormone replacement therapy. Am J Obstet Gynecol 1995;172:562–567.